Cuin a bhios Regeneron Pharmaceuticals, Inc. a 'foillseachadh aithris prothaid is call?
Tha aithris prothaid is call Regeneron Pharmaceuticals, Inc. air fhoillseachadh aon uair sa cheathramh; chaidh an aithisg mu dheireadh de thoraidhean ionmhais Regeneron Pharmaceuticals, Inc. fhoillseachadh air 31/03/2021.
Dè a 'phrothaid bho na h-earrannan de Regeneron Pharmaceuticals, Inc.?
B 'e tuairmse de chosnaidhean gach roinn de Regeneron Pharmaceuticals, Inc. 9.89 $ anns an aithisg ionmhais mu dheireadh.
Cuin a dh'fhoillsicheas Regeneron Pharmaceuticals, Inc. an ath aithris prothaid agus call?
Bidh an ath aithisg air a 'chunntas prothaid is call Regeneron Pharmaceuticals, Inc. air An t-Ògmhios 2024.
Regeneron Pharmaceuticals, Inc. cosnadh gach cuibhreann den chompanaidh - aon de na comharran air teachd-a-steach a ’chompanaidh bho mheud a luach. Tha cosnadh gach cuibhreann air a thomhas gu sìmplidh - prothaid na companaidh air fad airson na h-ùine ionmhais aithriseach air a roinn leis an àireamh de earrannan. Tha Regeneron Pharmaceuticals, Inc. cosnadh gach cuibhreann air a thomhas airson gach àm ionmhais. Prothaid Regeneron Pharmaceuticals, Inc. - prothaid iomlan a ’chompanaidh san ùine aithris.
|
Brabac Regeneron Pharmaceuticals, Inc.
Tha na prothaidean Regeneron Pharmaceuticals, Inc. nan iomradh. Chan eil e cho cudromach do luchd-earrannan prìobhaideach. Tha barrachd ùidh aig luchd-earrannan ann an cosnadh gach cuibhreann. Tha e gu sònraichte a ’toirt buaidh air na earrannan a fhuaireadh air earrannan. Tha ceann-latha an aithris teachd-a-steach de Regeneron Pharmaceuticals, Inc. air a stèidheachadh leis an lagh agus riaghailtean na buidhne. Tha cinn-latha aithrisean prothaid Regeneron Pharmaceuticals, Inc. airson amannan o chionn ghoirid air an sealltainn ann an clàr agus graf na seirbheis air-loidhne againn.
|
Prothaid ràitheil Regeneron Pharmaceuticals, Inc.
Cosnadh gach cuibhreann Regeneron Pharmaceuticals, Inc. air a thomhas le bhith a ’roinn teachd-a-steach lom leis an àireamh de earrannan sa chompanaidh. Tha cosnadh gach cuibhreann Regeneron Pharmaceuticals, Inc. na chomharradh air àm ionmhais sònraichte. Tha e furasta a bhith a ’tomhas gu bheil an ùine ionmhais a’ dol aig an aon àm ri foillseachadh aithrisean ionmhais air prothaid. Tha cosnadh Regeneron Pharmaceuticals, Inc. gach roinn airson na h-ùine as ùire air a ’ghraf sa cholbh as fhaide air falbh. Is e prothaid ràitheil Regeneron Pharmaceuticals, Inc. an seòrsa aithisg ionmhais as cumanta airson anailisean ionmhais.
|
|
Ceann-là aithisg REGN
|
Tuarastal airson gach roinn
Tha tuarastalan gach co-roinn air an tomhas le bhith a 'roinneadh teachd-a-steach (no prothaid) lìon le àireamh nan earrannan den chompanaidh.
|
Atharrachadh airson na bliadhna %
|
|
31/03/2021 |
9.89 USD |
- |
|
31/12/2020 |
9.53 USD |
+27.07% ↑ |
|
30/09/2020 |
8.36 USD |
+25.34% ↑ |
|
30/06/2020 |
7.16 USD |
+18.94% ↑ |
|
31/12/2019 |
7.5 USD |
+23.6% ↑ |
|
30/09/2019 |
6.67 USD |
+23.9% ↑ |
|
30/06/2019 |
6.02 USD |
+15.2% ↑ |
|
31/03/2019 |
4.45 USD |
+25.67% ↑ |
|
31/12/2018 |
6.84 USD |
+23.67% ↑ |
|
30/09/2018 |
5.87 USD |
+33.36% ↑ |
|
30/06/2018 |
5.45 USD |
+48.26% ↑ |
|
31/03/2018 |
4.67 USD |
+42.19% ↑ |
|
31/12/2017 |
5.23 USD |
+49.53% ↑ |
|
30/09/2017 |
3.99 USD |
+42.21% ↑ |
|
30/06/2017 |
4.17 USD |
+19.56% ↑ |
|
31/03/2017 |
2.92 USD |
+18.6% ↑ |
|
31/12/2016 |
3.04 USD |
-10.934% ↓ |
|
30/09/2016 |
3.13 USD |
-18.0598% ↓ |
|
30/06/2016 |
2.82 USD |
-4.6082% ↓ |
|
31/03/2016 |
2.57 USD |
-3.929% ↓ |
|
31/12/2015 |
2.83 USD |
+19.27% ↑ |
|
30/09/2015 |
3.47 USD |
+24.15% ↑ |
|
30/06/2015 |
2.89 USD |
+20.76% ↑ |
|
31/03/2015 |
2.88 USD |
+21.93% ↑ |
|
31/12/2014 |
2.79 USD |
+186.59% ↑ |
|
30/09/2014 |
2.52 USD |
+184.61% ↑ |
|
30/06/2014 |
2.47 USD |
+161.62% ↑ |
|
31/03/2014 |
2.26 USD |
+124.92% ↑ |
|
31/12/2013 |
0.86 USD |
-11.887% ↓ |
|
30/09/2013 |
1.25 USD |
-4.49% ↓ |
|
30/06/2013 |
0.79 USD |
+229.25% ↑ |
|
31/03/2013 |
0.9 USD |
-525.274% ↓ |
|
31/12/2012 |
1.22 USD |
-283.005% ↓ |
|
30/09/2012 |
1.72 USD |
-224.67% ↓ |
|
30/06/2012 |
0.7 USD |
-165.249% ↓ |
|
31/03/2012 |
0.16 USD |
-35.754% ↓ |
|
31/12/2011 |
-0.54 USD |
-46.397% ↓ |
|
30/09/2011 |
-0.68 USD |
-55.541% ↓ |
|
30/06/2011 |
-0.69 USD |
-8.163% ↓ |
|
31/03/2011 |
-0.49 USD |
-27.125% ↓ |
|
31/12/2010 |
-0.17 USD |
-4.041% ↓ |
|
30/09/2010 |
-0.41 USD |
-40.356% ↓ |
|
30/06/2010 |
-0.31 USD |
-24.533% ↓ |
|
31/03/2010 |
-0.38 USD |
-37.15% ↓ |
|
31/12/2009 |
-0.46 USD |
-10.266% ↓ |
|
30/09/2009 |
-0.01 USD |
-36.693% ↓ |
|
30/06/2009 |
-0.19 USD |
-7.213% ↓ |
|
31/03/2009 |
-0.22 USD |
-4.792% ↓ |
|
31/12/2008 |
-0.4 USD |
-36.514% ↓ |
|
30/09/2008 |
-0.27 USD |
-5.0614% ↓ |
|
30/06/2008 |
-0.23 USD |
-28.793% ↓ |
|
31/03/2008 |
-0.15 USD |
-34.619% ↓ |
|
31/12/2007 |
-0.19 USD |
-6.74% ↓ |
|
30/09/2007 |
-0.54 USD |
-46.365% ↓ |
|
30/06/2007 |
-0.41 USD |
-24.189% ↓ |
|
31/03/2007 |
-0.46 USD |
-19.13% ↓ |
|
31/12/2006 |
-0.51 USD |
-22.237% ↓ |
|
30/09/2006 |
-0.48 USD |
-5.28% ↓ |
|
30/06/2006 |
-0.41 USD |
-8.85% ↓ |
|
31/03/2006 |
-0.36 USD |
-55% ↓ |
|
31/12/2005 |
-0.53 USD |
-44.648% ↓ |
|
30/09/2005 |
-0.52 USD |
-33.258% ↓ |
|
30/06/2005 |
-0.38 USD |
-41.101% ↓ |
|
31/03/2005 |
-0.07 USD |
-36.307% ↓ |
|
31/12/2004 |
0.05 USD |
-31.698% ↓ |
|
30/09/2004 |
-0.2 USD |
-24.571% ↓ |
|
30/06/2004 |
-0.26 USD |
-45.346% ↓ |
|
31/03/2004 |
1.06 USD |
-48.718% ↓ |
|
31/12/2003 |
-0.35 USD |
-37.463% ↓ |
|
30/09/2003 |
-0.52 USD |
-32.692% ↓ |
|
30/06/2003 |
-0.58 USD |
-12.941% ↓ |
|
31/03/2003 |
-0.68 USD |
-26.331% ↓ |
|
31/12/2002 |
-0.81 USD |
- |
|
30/09/2002 |
-0.75 USD |
- |
|
30/06/2002 |
-0.69 USD |
- |
|
31/03/2002 |
-0.58 USD |
- |
Tha Regeneron Pharmaceuticals, Inc. cosnadh gach ràithe mar thomhas de phrothaid na companaidh. Ach tha nas lugha de dh'iarrtas ann na prothaid na bliadhna air aon roinn. Tha prothaid ràitheil mu dheireadh Regeneron Pharmaceuticals, Inc. a-nis air a mheas mar phrothaid ràitheil airson a ’cheathramh fiosgail dùinte mu dheireadh den bhliadhna seo. Tha atharrachadh ann an prothaid Regeneron Pharmaceuticals, Inc. airson na bliadhna na luach àireamhaichte airson fiosrachadh a bharrachd a tha a ’sealltainn an atharrachadh sa cheud de phrothaid leis an aon eadar-ama den bhliadhna mu dheireadh. Chan eil atharrachadh ann an Regeneron Pharmaceuticals, Inc. prothaid ràitheil airson na bliadhna cho cudromach ri atharrachadh ann an prothaid bliadhnail Regeneron Pharmaceuticals, Inc. an coimeas ris an-uiridh.
Airson goireasachd tuigse agus anailis, bidh sinn a ’foillseachadh an atharrachaidh ann am prothaid mar cheudad. Tha eachdraidh prothaid Regeneron Pharmaceuticals, Inc. airson bliadhnaichean roimhe air a thoirt seachad anns a ’chlàr againn“ Prothaid ràitheil ”. Regeneron Pharmaceuticals, Inc. tha eachdraidh cosnaidh ràitheil ri fhaighinn air-loidhne thairis air na 10 bliadhna a dh ’fhalbh. Tha Regeneron Pharmaceuticals, Inc. stòr-dàta prothaid air-loidhne airson amannan ùine air a chur ri chèile bho stòran oifigeil dearbhte fad na h-ùine.
|
